EUVIMEDEUVIMED entdecken
Open Access

Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant Treatment

Natsuko Onishi iD, Teffany Joy Bareng, Jessica Gibbs iD, Wen Li iD, Elissa R Price iD, Bonnie N Joe iD, John Kornak iD, Laura J Esserman iD, David C Newitt iD, Nola M Hylton iD, I-SPY 2 Imaging Working Group, I-SPY 2 Investigator Network

Radiology: Imaging Cancer · 01.07.2023 · 5 (4)

DOI: 10.1148/rycan.220126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiology: Imaging Cancer, erschienen am 01.07.2023. Verfasst von Natsuko Onishi und 11 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Radiology and Biomedical Imaging (N.O., T.J.B., J.G., W.L., E.R.P., B.N.J., D.C.N., N.M.H.), Department of Epidemiology and Bi…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To investigate the impact of longitudinal variation in functional tumor volume (FTV) underestimation and overestimation in predicting pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC). Materials and Methods Women with breast cancer who were enrolled in the prospective I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2) from May 2010 to November 2016 were eligible for this retrospective analysis. Participants underwent four MRI examinations during NAC treatment. FTV was calculated based on automated segmentation. Baseline FTV before treatment (FTV0) and the percentage of FTV change at early treatment and inter-regimen time points relative to baseline (∆FTV1 and ∆FTV2, respectively) were classified into high-standard or standard groups based on visual assessment of FTV under- and overestimation. Logistic regression models predicting pCR using single predictors (FTV0, ∆FTV1, and ∆FTV2) and multiple predictors (all three) were developed using bootstrap resampling with out-of-sample data evaluation with the area under the receiver operating characteristic curve (AUC) independently in each group.

Results

This study included 432 women (mean age, 49.0 years ± 10.6 [SD]). In the FTV0 model, the high-standard and standard groups showed similar AUCs (0.61 vs 0.62). The high-standard group had a higher estimated AUC compared with the standard group in the ∆FTV1 (0.74 vs 0.63), ∆FTV2 (0.79 vs 0.62), and multiple predictor models (0.85 vs 0.64), with a statistically significant difference for the latter two models (P = .03 and P = .01, respectively).

Conclusion

The findings in this study suggest that longitudinal variation in FTV estimation needs to be considered when using early FTV change as an MRI-based criterion for breast cancer treatment personalization. Keywords: Breast, Cancer, Dynamic Contrast-enhanced, MRI, Tumor Response ClinicalTrials.gov registration no. NCT01042379 Supplemental material is available for this article. © RSNA, 2023 See also the commentary by Ram in this issue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsFemaleHumansMiddle AgedNeoadjuvant TherapyTumor BurdenRetrospective StudiesProspective StudiesTreatment OutcomeMagnetic Resonance Imaging

Stichwörter der Autor:innen

BreastCancerDynamic Contrast-enhancedMRITumor Response

Autor:innen und Institutionen

  • From the Department of Radiology and Biomedical Imaging (N.O., T.J.B., J.G., W.L., E.R.P., B.N.J., D.C.N., N.M.H.), Department of Epidemiology and Biostatistics (J.K.), and Department of Surgery (L.J.E.), University of…

ORCID-Profile: Natsuko Onishi, Jessica Gibbs, Wen Li, Elissa R Price, Bonnie N Joe, John Kornak, Laura J Esserman, David C Newitt, Nola M Hylton

Förderung

  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Onishi, N., Bareng, T. J., Gibbs, J., Li, W., Price, E. R., Joe, B. N., Kornak, J., Esserman, L. J., Newitt, D. C., Hylton, N. M., I-SPY 2 Imaging Working Group, & I-SPY 2 Investigator Network (2023). Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant Treatment. Radiology: Imaging Cancer, 5(4). https://doi.org/10.1148/rycan.220126

Vancouver

Onishi N, Bareng TJ, Gibbs J, Li W, Price ER, Joe BN, et al. Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant Treatment. Radiology: Imaging Cancer. 2023;5(4). doi:10.1148/rycan.220126

BibTeX
@article{Onishi2023,
  author = {Onishi, Natsuko and Bareng, Teffany Joy and Gibbs, Jessica and Li, Wen and Price, Elissa R and Joe, Bonnie N and Kornak, John and Esserman, Laura J and Newitt, David C and Hylton, Nola M and I-SPY 2 Imaging Working Group, I-SPY 2 Imaging Working Group and I-SPY 2 Investigator Network, I-SPY 2 Investigator Network},
  title = {Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant Treatment},
  journal = {Radiology: Imaging Cancer},
  year = {2023},
  volume = {5},
  number = {4},
  doi = {10.1148/rycan.220126}
}
Kostenlos starten →